FI932641A - Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner - Google Patents

Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner Download PDF

Info

Publication number
FI932641A
FI932641A FI932641A FI932641A FI932641A FI 932641 A FI932641 A FI 932641A FI 932641 A FI932641 A FI 932641A FI 932641 A FI932641 A FI 932641A FI 932641 A FI932641 A FI 932641A
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
estradiolderivat
chlorambucyl
nytt
conjugates
Prior art date
Application number
FI932641A
Other languages
English (en)
Other versions
FI932641A0 (fi
Inventor
Fumio Tamura
Tsuyoshi Saito
Satoshi Mitsuhashi
Tadahiro Matsudaira
Kiro Asano
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of FI932641A0 publication Critical patent/FI932641A0/fi
Publication of FI932641A publication Critical patent/FI932641A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI932641A 1992-06-11 1993-06-09 Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner FI932641A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4177363A JP2520074B2 (ja) 1992-06-11 1992-06-11 新規なエストラジオ―ル誘導体−クロラムブチル結合体、その製造方法、及び医薬製剤

Publications (2)

Publication Number Publication Date
FI932641A0 FI932641A0 (fi) 1993-06-09
FI932641A true FI932641A (fi) 1993-12-12

Family

ID=16029655

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932641A FI932641A (fi) 1992-06-11 1993-06-09 Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner

Country Status (11)

Country Link
US (3) US5354745A (fi)
EP (1) EP0573977B1 (fi)
JP (1) JP2520074B2 (fi)
KR (1) KR970001532B1 (fi)
AT (1) ATE166060T1 (fi)
AU (1) AU649180B2 (fi)
CA (1) CA2097137A1 (fi)
DE (1) DE69318474T2 (fi)
FI (1) FI932641A (fi)
IL (1) IL105901A0 (fi)
ZA (1) ZA933993B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
US6500669B1 (en) * 1994-05-04 2002-12-31 Massachusetts Institute Of Technology Programmable genotoxic agents and uses therefor
US5882941A (en) * 1994-05-04 1999-03-16 Massachusette Institute Of Technology Programmable genotoxic agents and uses therefor
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6929797B2 (en) * 1997-02-13 2005-08-16 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6534037B1 (en) 1998-01-21 2003-03-18 Neorx Corporation Non-steroidal compounds for steroid receptors and uses relating thereto
US7138502B2 (en) * 2000-09-28 2006-11-21 Yale University Antibodies to the propeptide of Candida albicans and methods of use
US20120225849A1 (en) * 2011-03-01 2012-09-06 The University Of Kansas 2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition
CN103772463B (zh) * 2013-12-30 2016-06-22 郑州大学 2-甲氧基雌二醇类似物及其制备方法与用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950292A (en) * 1959-06-29 1960-08-23 Searle & Co 3-alkoxy-16-alkyl-16-hydroxy-1, 3, 5(10)-estratrien-17-ones, their ethers and esters
US3086033A (en) * 1960-03-11 1963-04-16 Merck Ag E 1-methyl-17-alkyl-11-oxygenated delta1, 3, 5 (10)-estrogenic compounds
US3031469A (en) * 1961-10-24 1962-04-24 American Cyanamid Co New 15, 17-disubstituted-1, 3, 5(10)-estratriens and method of preparing the same
NL6405462A (fi) * 1963-05-17 1964-11-18
FR4339M (fi) * 1965-03-29 1966-08-08
US3449383A (en) * 1967-02-16 1969-06-10 Searle & Co 17-oxygenated estra-1,3,5(10)-triene-3,11beta,16-triols,ethers and esters thereof
US3496168A (en) * 1967-09-12 1970-02-17 Smithkline Corp 4-alkoxyestradiols
DE2402482C2 (de) * 1974-01-16 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 3-Ketosteroiden durch elektrochemische Reduktion von α,β -ungesättigten 3-Ketosteroiden
US4096253A (en) * 1976-07-06 1978-06-20 Ortho Pharmaceutical Corporation 1-Oxygenated steroids
US4260736A (en) * 1978-08-14 1981-04-07 Kureha Kagaku Kogyo Kabushiki Kaisha Steroid hormone-antitumor derivatives
US4261910A (en) * 1978-08-14 1981-04-14 Kureha Kagaku Kogyo Kabushiki Kaisha Process for the preparation of Chlorambucil derivatives
JPS56110700A (en) * 1980-02-08 1981-09-01 Kureha Chem Ind Co Ltd Estradiol-17alphaderivative and ist antitumor agent
SE8305596D0 (sv) * 1983-10-12 1983-10-12 Leo Ab A selective acylation method
DE3510555A1 (de) * 1985-03-21 1986-09-25 Schering AG, 1000 Berlin und 4709 Bergkamen Estriolester
JPS61293993A (ja) * 1985-06-21 1986-12-24 Kureha Chem Ind Co Ltd 新規な螢光物質，その製造方法及び薬剤
US4882439A (en) * 1985-09-19 1989-11-21 The University Of Sheffield Steroid intermediates
EP0240717A3 (en) * 1986-03-04 1990-05-16 Board of Regents of the University of Nebraska Prevention of mammary carcinoma
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
JPH0794377B2 (ja) * 1987-07-22 1995-10-11 呉羽化学工業株式会社 エストラジオール誘導体を含有する注射剤
JPS6445393A (en) * 1987-08-13 1989-02-17 Toa Nenryo Kogyo Kk Estradiol derivative
JPS6445392A (en) * 1987-08-13 1989-02-17 Toa Nenryo Kogyo Kk Production of estradiol derivative
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
US5031469A (en) * 1988-11-30 1991-07-16 Blackburn Robert E Fluid sampler
CA2123472C (en) * 1994-05-12 2005-07-05 Craig W. Renwick Injection molding manifold and method with the heating element extending between the plates

Also Published As

Publication number Publication date
EP0573977A3 (en) 1996-01-31
JP2520074B2 (ja) 1996-07-31
US5576309A (en) 1996-11-19
DE69318474T2 (de) 1998-10-15
EP0573977A2 (en) 1993-12-15
KR940005662A (ko) 1994-03-22
US5354745A (en) 1994-10-11
US5578589A (en) 1996-11-26
ATE166060T1 (de) 1998-05-15
KR970001532B1 (ko) 1997-02-11
DE69318474D1 (de) 1998-06-18
ZA933993B (en) 1994-01-05
FI932641A0 (fi) 1993-06-09
AU649180B2 (en) 1994-05-12
IL105901A0 (en) 1993-10-20
CA2097137A1 (en) 1993-12-12
EP0573977B1 (en) 1998-05-13
JPH05339285A (ja) 1993-12-21
AU4011693A (en) 1993-12-16

Similar Documents

Publication Publication Date Title
NZ227251A (en) Macrolide derivatives and pharmaceutical compositions
AU586691B2 (en) Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them
HK116296A (en) Amide derivatives and dermatologic preparations containing the same
CA2023645A1 (fr) Procede pour la preparation enantioselective de derives de la phenylisoserine
ZA898678B (en) Compositions and compounds
CA2053820A1 (en) Method of Inhibiting Metabolism of Cholesterol
FI932641A (fi) Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner
HUT59693A (en) Process for producing morpholinyl derivatives of doxorubicin and pharmaceutical compositions containing them
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
WO1993025568A3 (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
EP0385446A3 (en) Osteogenesis promotion with use of vitamin d derivatives
IL63747A (en) Cardenolide bis-digitoxosides,processes for the preparation thereof and pharmaceutical compositions containing them
SE9701912D0 (sv) Pharmaceutical composition and use thereof
JPS6426554A (en) Novel derivative of 1-benzoyl-2-oxo-5-alkoxy pyrrolidine, manufacture, use as drug and composition
NO913855L (no) Termoplastiske stoepeblandinger.
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도